Evidence map›Paper›PMID 27882197›Full record

ArticleACS medicinal chemistry letters2016

Site-Specific Tandem Knoevenagel Condensation-Michael Addition To Generate Antibody-Drug Conjugates.

Romas A Kudirka, Robyn M Barfield, Jesse M McFarland, Penelope M Drake, Adam Carlson, Stefanie Bañas, Wes Zmolek, Albert W Garofalo, David Rabuka

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Introduction of Carbonyl Groups into Antibodies.Molecules (Basel, Switzerland) · 2023
    Review
  3. Review
  4. Article
  5. Bivalent EGFR-Targeting DARPin-MMAE Conjugates.International journal of molecular sciences · 2022
    Article
  6. Review
  7. Review
  8. Bifunctional Reagents for Formylglycine Conjugation: Pitfalls and Breakthroughs.Chembiochem : a European journal of chemical biology · 2020
    Article
  9. Article
  10. Click Chemistry Conjugations.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Romas A KudirkaCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Robyn M BarfieldCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Jesse M McFarlandCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Penelope M DrakeCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Adam CarlsonCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Stefanie BañasCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Wes ZmolekCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
Albert W GarofaloCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.
David RabukaCatalent Biologics West , 5703 Hollis Street, Emeryville, California 94530, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expanded ligation techniques are sorely needed to generate unique linkages for the growing field of functionally enhanced proteins. To address this need, we present a unique chemical ligation that involves the double addition of a pyrazolone moiety with an aldehyde-labeled protein. This ligation occurs via a tandem Knoevenagel condensation-Michael addition. A pyrazolone reacts with an aldehyde to generate an enone, which undergoes subsequent attack by a second pyrazolone to generate a bis-pyrazolone species. This rapid and facile ligation technique is performed under mild conditions in the absence of catalyst to generate new architectures that were previously inaccessible via conventional ligation reactions. Using this unique ligation, we generated three site-specifically labeled antibody-drug conjugates (ADCs) with an average of four drugs to one antibody. The in vitro and in vivo efficacies along with pharmacokinetic data of the site-specific ADCs are reported.

Indexed as

Antibody−drug conjugate (ADC)bivalent drugssite-specific bioconjugationtandem reactions

Identifiers

PMID27882197
PMCPMC5108035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.